RHO and cancer: Our results with pharmacological inhibitors of MLCK and ROCK pathways illustrate the prominent role of ROCK pathway in cell contractility, cortical stiffness and ECM degradation of stem-like cells, and are consistent with the upregulation of Rho signaling pathway observed in various cancers [26–28].